We make medicines with the patient in mind
Precision medicine for the brain is here. We are pioneering an approach to psychiatric drug development which matches the right patient with the right Alto drug based on AI-derived brain biomarkers.
Led by founder Amit Etkin, MD, PhD, we are driven to help people with mental health conditions get better faster.
Data-driven Biomarker Platform
We are redefining psychiatry with AI-driven brain biomarkers that align the right patient with the right Alto drug, leveraging the richest in-human data set specifically built for precision psychiatry. Our work builds on a decade of clinical neuroscience research.
Leading Clinical-Stage Pipeline
With multiple medicines in our pipeline for mental health conditions, including depression and post-traumatic stress disorder (PTSD), we are moving swiftly to quickly identify the right patients for each drug and combat the spiraling mental health crisis.